EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.22.B60 | benzoyl-Phe-Val-Arg-4-methylcoumarinyl-7-amide + H2O |
cathepsin L2 |
Fasciola hepatica |
benzoyl-Phe-Val-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Arg-4-methylcoumarinyl-7-amide + H2O |
cathepsin L2 |
Fasciola hepatica |
benzyloxycarbonyl-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Arg-Arg-4-methylcoumarinyl-7-amide + H2O |
cathepsin L2 |
Fasciola hepatica |
benzyloxycarbonyl-Arg-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-L-Leu-L-Arg-4-methylcoumarinyl-7-amide + H2O |
FhCL2 |
Fasciola hepatica |
benzyloxycarbonyl-L-Leu-L-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-L-Phe-L-Arg-4-methylcoumarinyl-7-amide + H2O |
FhCL2 |
Fasciola hepatica |
benzyloxycarbonyl-L-Phe-L-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-L-Pro-L-Arg-4-methylcoumarinyl-7-amide + H2O |
FhCL2 |
Fasciola hepatica |
benzyloxycarbonyl-L-Pro-L-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Leu-Arg-7-amido-4-methylcoumarin + H2O |
- |
Fasciola hepatica |
benzyloxycarbonyl-Leu-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Phe-Arg-4-methylcoumarinyl-7-amide + H2O |
cleaved by cathepsin L2 with much greater affinity than by cathepsin L1 |
Fasciola hepatica |
benzyloxycarbonyl-Phe-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin + H2O |
- |
Fasciola hepatica |
benzyloxycarbonyl-Phe-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B60 | benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin + H2O |
cathepsin L2 |
Fasciola hepatica |
benzyloxycarbonyl-Phe-Arg + 7-amino-4-methyl coumarin |
- |
? |